Please assess the completion status of the following clinical trial:

Trial Title: Clinical Evaluation of FLACS With Combination of LenSx® and Centurion®

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Cataracts (Grade 2-4 of Emery-Little Classification) with planned cataract removal by phacoemulsification in both eyes;~* Able to comprehend and willing to sign informed consent and complete all required postoperative follow-up procedures;~* Calculated lens power within the available range;~* Other protocol-specified inclusion criteria may apply.~Exclusion Criteria:~* Any pathology that could reduce visual potential;~* Hypotony or the presence of a corneal implant;~* Residual, recurrent, active ocular or eyelid disease;~* Poorly dilating pupil;~* Any contraindication to cataract;~* Eyes with two different levels of cataract grade;~* Pregnant, or planned pregnancy during the study;~* Expected to require an ocular surgical treatment at any time during the study;~* Other protocol-specified exclusion criteria may apply.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- FLACS (Type: EXPERIMENTAL): Femtosecond laser assisted cataract surgery (FLACS) in 1 eye, with manual conventional surgery in the fellow eye, as randomized
- Conventional (Type: ACTIVE_COMPARATOR): Manual conventional surgery in 1 eye, with FLACS in the fellow eye, as randomized

Based on this trial design, predict the completion outcome and termination type (if applicable).